Biocapture surfaces produced for study of brain chemistry
December 13, 2007 12:24 PM - Penn State
A research team at Penn State has developed a novel method for attaching small molecules, such as neurotransmitters, to surfaces, which then are used to capture large biomolecules. By varying the identity and spacing of the tethered molecules, researchers can make the technique applicable to a wide range of bait molecules including drugs, chemical warfare agents, and environmental pollutants. Ultimately, the researchers also hope to identify synthetic biomolecules that recognize neurotransmitters so that they can fabricate extremely small biosensors to study neurotransmission in the living brain.
Researchers Double Cell Phone Memory
December 13, 2007 12:21 PM - Northwestern University Newswire
EVANSTON, Ill. --- Cell phones are increasingly sophisticated -- sporting such features as cameras, music players, games, video clips, Internet access and, lest we forget, the capability to phone someone -- but these features come at a price: memory.
Attractiveness Is Its Own Reward
December 13, 2007 12:12 PM - California Institute of Technology Newswire
PASADENA, Calif. --Studies of the snap judgments we often make about people are shedding new light not only on social behavior, but also on drug abuse, gambling addiction, and other disorders in which our ability to make decisions is impaired, say scientists at the California Institute of Technology.
Managing manure in California
December 12, 2007 05:32 PM - Alec Rosenberg, UC Merced Newswire
Merced, California - A partnership between agricultural leaders and UC Merced aims to help California farmers maintain the environment and the economy.
California is the nation's leading dairy state, generating $5.2 billion in milk and cream sales a year. While that keeps the state's 1.7 million dairy cows busy making milk, they also produce plenty of manure. The manure is filled with nutrients that farmers can use as fertilizer, but it also can pollute the environment.
First face transplant worth the fuss, patient says
December 12, 2007 05:08 PM - Gene Emery, Reuters
BOSTON (Reuters) - It took 18 months for her smile to come back completely, but doctors say the French woman who received the world's first partial face transplant is doing well and is very satisfied with the results.
Chemicals used as fire retardants could be harmful
December 12, 2007 05:02 PM - UC Riverside, Newswire
Riverside, California - Polybrominated diphenyl ethers (PBDEs), chemicals used as fire retardants, can be found in numerous items in the home, such as the television, computer, toaster and the sofa. Now, as reported in a news story days ago, they are being found in alarming concentrations, in human blood and breast milk – a potentially major concern for human health.
Canadian museum unveils long, long-lost dinosaur
December 12, 2007 05:02 PM - Claire Sibonney, Reuters
TORONTO (Reuters) - Canada's Royal Ontario Museum unveiled the skeleton of a massive dinosaur on Wednesday that had been lost for decades -- in its own collection.
Satellite probes view auroral substorms, solar bowshock
December 12, 2007 04:55 PM - US Berkeley, Newswire
Berkeley, California -- Five satellites launched last February to probe magnetic storms around the Earth will move into prime observing position next month, but they already have produced important new information on the interactions between the solar wind and the Earth's magnetic field.
Cholesterol drugs may raise brain hemorrhage risk
December 12, 2007 04:33 PM - Reuters
NEW YORK (Reuters Health) - The use of cholesterol-lowering "statin" drugs, such as Lipitor (atorvastatin) and Zocor (simvastatin), may raise the risk of brain hemorrhage in patients who have experienced a recent stroke or a transient ischemic attack (TIA), new research suggests. Still, this risk may be outweighed by the ability of these agents to lower the overall risk of a second stroke and other serious events, such as heart attack.
FDA says Merck recalls 12 lots of kids' vaccines
December 12, 2007 04:32 PM - Reuters
The company recalled 10 lots of its PedvaxHIB vaccine and two lots of its Comvax vaccine, the Food and Drug Administration said in a notice on its Web site. Both vaccines protect against a common cause of pneumonia, meningitis and upper respiratory infections. Comvax also prevents hepatitis